Atlas Trials

Bortezomib, Ifosfamide, Carboplatin, and Etoposide, With or Without Rituximab, in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin Lymphoma

Clinical trial NCT00598169 · COMPLETED

Trial details

NCT number
NCT00598169
Sponsor
AIDS Malignancy Consortium
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Lymphoma
Start date
2007-11-01
Primary completion
2014-10-01
Enrollment
23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.